Solventum Corporation SOLV NYSE

Solventum Corporation (SOLV) generated $369M in operating cash flow for fiscal year 2025. After capital expenditures of $379M, free cash flow was $-10M.

Free cash flow margin was -0.1% of revenue. Cash conversion ratio was 0.24x, suggesting some earnings are non-cash.

Criteria supported by this page:

• HEALTH (50/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
• MOAT (71/100, Pass) — $-10M (-0.1% FCF margin) supports a durable competitive advantage
• INCOME (70/100) — Cash conversion ratio was 0.24x suggests some earnings are non-cash items

Overall SharesGrow Score: 73/100 with 6/7 criteria passed.